StockData
Incyte Corp logo

Incyte Corp (INCY) stock

INCYNasdaqServices-Commercial Physical & Biological ResearchFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 13/3091% above fair value
$119.09−1.18 (-0.98%)

Close on Nov 17, 2026Market cap $24.27BP/E 63.3Yield –

Incyte ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

Incyte's ebitda for the twelve months ending Sep 30, 2026 was $724.95M, down 53.9% year over year. For fiscal 2025 it was $1.61B, up 967.7% from the year before. Over ten years it grew 32.6% a year on average. The highest annual figure on record is $1.61B in fiscal 2025.

Annual ebitda

PeriodPeriod endValueChange
FY2025Dec 31, 2025$1.61B+967.7%
FY2024Dec 31, 2024$150.61M-78.6%
FY2023Dec 31, 2023$703.19M+8.6%
FY2022Dec 31, 2022$647.30M+0.6%
FY2021Dec 31, 2021$643.62M–
FY2020Dec 31, 2020-$211.87M-146.4%
FY2019Dec 31, 2019$456.54M+147.9%
FY2018Dec 31, 2018$184.19M–
FY2017Dec 31, 2017-$191.21M-194.0%
FY2016Dec 31, 2016$203.42M+112.9%
FY2015Dec 31, 2015$95.53M+161.0%
FY2014Dec 31, 2014$36.61M+179.4%
FY2013Dec 31, 2013$13.11M-57.9%
FY2012Dec 31, 2012$31.13M–
FY2011Dec 31, 2011-$116.19M-401.5%
FY2010Dec 31, 2010$38.53M–
FY2009Dec 31, 2009-$123.08M–

Quarterly ebitda

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026-$684.19M-246.3%
Q2 FY2026Jun 30, 2026$724.37M+30.9%
Q1 FY2026Mar 31, 2026$324.92M+42.8%
Q4 FY2025Dec 31, 2025$359.84M+11.0%
Q3 FY2025Sep 30, 2025$467.54M+177.3%
Q2 FY2025Jun 30, 2025$553.23M–
Q1 FY2025Mar 31, 2025$227.53M+99.9%
Q4 FY2024Dec 31, 2024$324.25M+55.1%
Q3 FY2024Sep 30, 2024$168.61M-28.6%
Q2 FY2024Jun 30, 2024-$456.08M-313.0%
Q1 FY2024Mar 31, 2024$113.85M+158.9%
Q4 FY2023Dec 31, 2023$209.03M+136.7%
Q3 FY2023Sep 30, 2023$236.10M+52.3%
Q2 FY2023Jun 30, 2023$214.08M-21.0%
Q1 FY2023Mar 31, 2023$43.98M-66.9%
Q4 FY2022Dec 31, 2022$88.31M-29.7%
Q3 FY2022Sep 30, 2022$155.07M-38.0%
Q2 FY2022Jun 30, 2022$270.94M+74.5%
Q1 FY2022Mar 31, 2022$132.98M+18.1%
Q4 FY2021Dec 31, 2021$125.59M-29.2%
Q3 FY2021Sep 30, 2021$250.10M+1268.5%
Q2 FY2021Jun 30, 2021$155.29M-36.2%
Q1 FY2021Mar 31, 2021$112.64M–
Q4 FY2020Dec 31, 2020$177.40M+63.7%
Q3 FY2020Sep 30, 2020$18.28M-87.7%
Q2 FY2020Jun 30, 2020$243.37M+117.2%
Q1 FY2020Mar 31, 2020-$650.91M-840.0%
Q4 FY2019Dec 31, 2019$108.35M+12.6%
Q3 FY2019Sep 30, 2019$148.18M+229.7%
Q2 FY2019Jun 30, 2019$112.05M+15.8%
Q1 FY2019Mar 31, 2019$87.96M–
Q4 FY2018Dec 31, 2018$96.20M–
Q3 FY2018Sep 30, 2018$44.94M+66.7%
Q2 FY2018Jun 30, 2018$96.74M+393.3%
Q1 FY2018Mar 31, 2018-$53.69M–
Q4 FY2017Dec 31, 2017-$119.56M-300.5%
Q3 FY2017Sep 30, 2017$26.96M–
Q2 FY2017Jun 30, 2017$19.61M–
Q1 FY2017Mar 31, 2017-$118.22M–
Q4 FY2016Dec 31, 2016$59.65M–

More Incyte figures

See a number that looks wrong?